Typing for Transplant, valued at US$1.0 billion in 2024, is forecasted to grow at a robust CAGR of 6.0 %, reaching US$1.1 billion in 2025 and an impressive US$1.4 billion by 2030. The escalating ...

Illumina, Inc. (NASDAQ:ILMN) collaborates with Signios Bio to launch a grant for advancements in proteomics using ...

AI in Precision Medicine Market is revolutionizing healthcare with data-driven solutions and personalized treatments. Explore insights on market size, share, trends, and forecast up to 2035.

Overview of Genomics in Cancer Care MarketThe Global Genomics in Cancer Care Market is valued at USD 24.5 Billion in 2024 and ...

Illumina, Inc. ILMN recently unveiled the DRAGEN version 4.4 software (v4.4), the industry's most comprehensive secondary analysis solution. The latest version includes out-of-the-box oncology ...

Preconfigured applications: DRAGEN v4.4 will offer "push-button" analysis for oncology workflows, including the first and ...

Epigenetics research in Japan is poised for significant growth, driven by advances in biotechnology and a growing emphasis on personalized medicine. As the rest of the world leans towards more ...

Illumina faces significant challenges, including revenue declines, margin pressures, and geopolitical hurdles. Read how ILMN ...

The global In Vitro Diagnostics Market, valued at US$100,769.3 million in 2024, is forecasted to grow at a robust CAGR of 7.6%, reaching US$109 ...

Machine identities—and their credentials allowing our applications, containers, APIs, and automated processes to authenticate and communicate—have exploded in number, creating what Gartner has ...